Product Reviews Clinical analysis

Thorne NiaCel 400 Review: Label, Testing, Dose and Evidence

Thorne NiaCel 400 review: current label, NR hydrogen malate, betaine, NSF listing, serving cost, human evidence and ResveraCel comparison.

Published
Last reviewed
Reading time
7 min
Sources cited
8
On this page

Thorne NiaCel 400 is a two-active-ingredient NR formula with an identifiable NSF Certified for Sport listing. The current official panel lists 415 mg NR hydrogen malate and 85 mg betaine per one-capsule serving. The number in the product name should not replace that current label or be treated as a direct measure of NR alone.

This review uses current official information, the certification listing and primary research, checked October 22, 2026. It is a desk-based assessment without a personal-use trial or independent assay. Biohack Blueprint has a disclosed affiliate relationship with DoNotAge, an alternative discussed below.

Current label and directions

The official product page lists 60 capsules, a one-capsule serving and 60 servings per container. The checked US price is $74, with directions to take one capsule daily or as recommended by the healthcare practitioner.

Detail Current checked information
NR form Nicotinamide riboside hydrogen malate
Declared salt amount 415 mg per capsule
Betaine anhydrous 85 mg per capsule
Capsule count 60
Serving size 1 capsule
Other ingredients Hypromellose capsule and ascorbyl palmitate
US price $74 before additional costs

The one-capsule serving is important. Older retailer directions or product reviews may describe another routine or version. Use the current bottle and official panel rather than averaging conflicting descriptions.

What the “400” does not establish

The product name is not a substitute for a compositional specification. The panel explicitly says 415 mg NR hydrogen malate. That salt amount includes a counterion and should not silently become 415 mg of NR alone.

A larger raw salt mass does not automatically establish greater NR exposure than a 300 mg chloride preparation. A verified NR-equivalent basis and, where necessary, direct exposure data would be needed for that comparison.

The NR forms guide explains why salt mass, delivery system and reduced NRH are different issues. “Hydrogen malate” is not another name for reduced NRH.

The certification is product-specific

The NSF Certified for Sport listing identifies Thorne NiaCel 400, a 60-capsule package with a one-capsule serving, and lists specific lots. That is a concrete, product-specific source rather than a generic statement that the manufacturer is reputable.

For an athlete subject to testing, the exact product and current lot should still be checked against the certification listing and the relevant governing-body requirements. A listing for NiaCel does not automatically extend to every Thorne product or every future formulation.

Certification also does not establish that NR improves athletic performance or slows aging. It addresses its stated quality and sport-related scope, which is valuable for a different reason from clinical efficacy.

Human NR research and the salt distinction

Much of the oral NR human literature concerns specified NR chloride preparations. The 140-person eight-week study demonstrated dose-dependent whole-blood NAD+ increases with 100, 300 and 1,000 mg/day of NR chloride. It did not test the current complete NiaCel hydrogen-malate-plus-betaine formula. [1]

The 2021 crystalline-salts paper provides relevant chemistry, while the 2022 hydrogen-malate safety report adds nonclinical toxicology and assay information. Those sources do not establish that NiaCel produces superior cognition, endurance or longevity in humans. [2] [3]

This distinction does not mean the salt is necessarily ineffective. It means that claims should be matched to what was actually tested, rather than transferring every chloride trial to a different finished preparation without qualification.

What is the purpose of the betaine?

Betaine, or TMG, is commonly discussed as a methyl donor. The mechanism creates a rationale for investigation, but it does not establish that the label's 85 mg amount is necessary or optimal for every NR user.

A short NADPARK companion analysis did not find broad disruption of the assessed methylation homeostasis. NR-SAFE also supplied high-dose NR without TMG and reported an initial homocysteine rise without depletion of the measured methyl-donor pool. Neither study randomized participants to the current NiaCel formula versus NR alone. [4] [5]

A manufacturer can reasonably include a supporting ingredient while its incremental clinical contribution remains uncertain. Do not turn the presence of betaine into proof that all standalone NR products are unsafe or incomplete.

Does it improve exercise performance?

A sport certification is not a performance trial. Likewise, a physiological pathway involved in energy metabolism is not evidence that every athlete will perform better after supplementation.

The 2026 Friedreich's ataxia study found a benefit of NR plus exercise relative to a no-exercise placebo condition, but the combination did not outperform exercise alone and NR alone did not meet the efficacy threshold. It involved a specific genetic disorder and supervised protocol, not a trial of NiaCel in healthy athletes. [6]

That comparator detail is essential. If a combination performs better than doing neither intervention, the result cannot automatically be credited to the supplement rather than the exercise.

Brain health and healthy aging claims

Current NR evidence is stronger for changing NAD-related biomarkers than for reliable improvements in memory or human longevity. The 2026 MCI trial roughly doubled blood NAD+ without improving cognition or total cerebral blood flow. [7]

The phase III NOPARK result also did not support Parkinson's disease modification. These are not studies of every NiaCel user, but they show why NAD biology alone cannot guarantee a clinical outcome. [8]

Our benefits review evaluates those outcomes directly. A clear formula and certification can help product selection without supplying the missing clinical efficacy result.

Price and supply

At $74 for 60 one-capsule servings, the checked price is approximately $1.23 per labeled serving. Thirty such servings cost about $37 by arithmetic. The bottle provides 60 days only if the actual agreed routine is one capsule daily.

These figures exclude shipping, taxes and future price changes. A different routine changes both cost and supply; the arithmetic is not advice to increase or reduce intake.

Do not compare cost per raw salt milligram with another form unless the amount basis is verified. A slightly cheaper number can be misleading when one label refers to hydrogen malate and another to chloride or a different declared basis.

NiaCel versus ResveraCel

The current ResveraCel serving includes the same declared NR hydrogen malate and betaine amounts, plus 150 mg trans-resveratrol and 250 mg quercetin phytosome, across two capsules. Its checked bottle provides 30 servings at $60, or $2.00 per serving.

NiaCel is therefore the simpler active formula among these two current products. ResveraCel may be convenient for a person who already wants the other ingredients, but more actives do not establish superior clinical benefit. See the ResveraCel review and combination analysis.

Legacy NiaCel versions should not be treated as separate evidence for the current formula without checking their labels. The same product family can change across time and markets.

Safety and individual suitability

Review the actual formula, medicines and intended goal with appropriate clinical input when relevant. Short NR-only tolerability studies do not establish the safety of every amount, duration or combination in every population.

Pregnancy, breastfeeding, childhood, significant illness and active cancer treatment need particular individual consideration. The safety guide explains these evidence gaps, and the cancer dossier separates preclinical findings from human risk estimates.

Do not interpret a sport certification or the absence of a known interaction statement as a complete medical assessment. Those sources answer different questions.

Who should consider NiaCel 400?

The strongest fit is a buyer who specifically values its current product-specific sport certification, one-capsule serving and relatively simple NR-plus-betaine formula. That may be more relevant than a generic brand ranking for an athlete with testing obligations.

Someone prioritizing a named NR chloride ingredient may instead compare Tru Niagen or Life Extension. Our DoNotAge review evaluates another simple formulation proposition with its current label conflict disclosed. None of these product preferences establishes a head-to-head clinical winner.

NiaCel's clearest strengths are the specific certification source and current concise label. Its limits are the need to preserve the salt amount basis and the absence of proof that the finished formula delivers every broad performance, brain-health or longevity claim. The best-NR guide compares those practical criteria.

Frequently asked questions

What is the current NiaCel 400 serving size?

The checked official panel lists one capsule, supplying 415 mg NR hydrogen malate and 85 mg betaine, with 60 servings per bottle.

Is NiaCel 400 NSF Certified for Sport?

The checked NSF listing identifies NiaCel 400 and specific lots. Verify the exact current product and lot; the listing does not establish clinical performance or cover every Thorne SKU.

Does 415 mg mean 415 mg NR alone?

The panel declares NR hydrogen malate, a salt. Do not silently relabel the amount as NR alone or assume raw milligram equivalence with another salt.

Is NiaCel better than ResveraCel?

They serve different formula preferences. NiaCel is the simpler current NR-plus-betaine formula, while ResveraCel adds resveratrol and quercetin phytosome. A universal clinical superiority result is not established.

How long does the bottle last?

It contains 60 labeled one-capsule servings. That is 60 days only at a one-capsule-daily routine; follow the actual directions and individual advice.

Share this article

Send the research to someone who would find it useful.

Facebook X LinkedIn Reddit WhatsApp Email

Sources & article history

Sources (8)
  1. Conze D, et al. Safety and Metabolism of Long-term Administration of NIAGEN (Nicotinamide Riboside Chloride) in a Randomized, Double-Blind, Placebo-controlled Clinical Trial of Healthy Overweight Adults Scientific reports. 2019;9; 1; 9772.
  2. Schabert G, et al. New Crystalline Salts of Nicotinamide Riboside as Food Additives Molecules (Basel, Switzerland). 2021;26; 9; 2729.
  3. Margitta Dziwenka, et al. Preclinical safety assessments of nicotinamide riboside hydrogen malate Toxicology Research and Application. 2022;6.
  4. Gaare JJ, et al. Nicotinamide riboside supplementation is not associated with altered methylation homeostasis in Parkinson's disease iScience. 2023;26; 3; 106278.
  5. Haakon Berven, et al. NR-SAFE: a randomized, double-blind safety trial of high dose nicotinamide riboside in Parkinson's disease Nature communications. 2023;14(1):7793.
  6. Lin KY, et al. Safety and efficacy of individualised exercise and NAD+ precursor supplementation in patients with Friedreich's ataxia in the USA: a single-centre, 2 × 2 factorial, randomised controlled trial The Lancet. Neurology. 2026;25; 5; 469-481.
  7. Martens CR, et al. A phase-II randomized controlled pilot study of nicotinamide riboside supplementation in older adults with amnestic mild cognitive impairment Alzheimer's & dementia : the journal of the Alzheimer's Association. 2026;22; 7; e71605.
  8. Brakedal B, et al. Nicotinamide Riboside for Patients With Early-Stage Parkinson Disease: The NOPARK Randomized Clinical Trial JAMA. 2026.
Article history (1)
  1. Published with cited human evidence, current formulation details and safety context.